114 related articles for article (PubMed ID: 8853970)
21. PAPNET-assisted rescreening of cervical smears: cost and accuracy compared with a 100% manual rescreening strategy.
O'Leary TJ; Tellado M; Buckner SB; Ali IS; Stevens A; Ollayos CW
JAMA; 1998 Jan; 279(3):235-7. PubMed ID: 9438746
[TBL] [Abstract][Full Text] [Related]
22. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
Goldie SJ; Weinstein MC; Kuntz KM; Freedberg KA
Ann Intern Med; 1999 Jan; 130(2):97-107. PubMed ID: 10068381
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of costs and benefits of advances in cytologic technology. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
Melamed MR; Hutchinson ML; Kaufman EA; Schechter CB; Garner D; Kobler TP; Krieger PA; Reith A; Schenck U
Acta Cytol; 1998; 42(1):69-75. PubMed ID: 9479325
[TBL] [Abstract][Full Text] [Related]
24. Screening for cervical cancer.
Eddy DM
Ann Intern Med; 1990 Aug; 113(3):214-26. PubMed ID: 2115753
[TBL] [Abstract][Full Text] [Related]
25. [Cost effectiveness analysis of screening strategies for cervical cancer in Tunisia].
Lazaar HB; Aounallah-Skhiri H; Oueslati F; Frikha H; Achour N; Hsairi M
East Mediterr Health J; 2010 Jun; 16(6):602-8. PubMed ID: 20799586
[TBL] [Abstract][Full Text] [Related]
26. [Health economics analysis of cervical cancer screening].
Boncz I; Sebestyén A; Pál M; Sándor J; Ember I
Orv Hetil; 2003 Apr; 144(15):713-7. PubMed ID: 12774432
[TBL] [Abstract][Full Text] [Related]
27. Towards effective cervical screening.
Havelock C; Havelock P
Practitioner; 1994 Apr; 238(1537):296-301. PubMed ID: 8183816
[No Abstract] [Full Text] [Related]
28. Cost effectiveness of cervical cancer screening for the elderly.
Fahs MC; Mandelblatt J; Schechter C; Muller C
Ann Intern Med; 1992 Sep; 117(6):520-7. PubMed ID: 1503355
[TBL] [Abstract][Full Text] [Related]
29. Cervical screening: what is the point?
Sasieni P
Lancet; 1995 Jul; 346(8969):244; author reply 246-7. PubMed ID: 7616810
[No Abstract] [Full Text] [Related]
30. Comparative cost-effectiveness of HPV vaccines in the prevention of cervical cancer in Malaysia.
Ezat SW; Aljunid S
Asian Pac J Cancer Prev; 2010; 11(4):943-51. PubMed ID: 21133606
[TBL] [Abstract][Full Text] [Related]
31. Cervical screening in older women.
Ogilvie D
Cytopathology; 2002 Oct; 13(5):333. PubMed ID: 12421452
[No Abstract] [Full Text] [Related]
32. The cost-effectiveness of cervical screening.
Smith WJ
Curr Opin Obstet Gynecol; 1999 Feb; 11(1):83-5. PubMed ID: 10047969
[No Abstract] [Full Text] [Related]
33. The cost-effectiveness of cervical-vaginal rescreening.
Raab SS
Am J Clin Pathol; 1997 Nov; 108(5):525-36. PubMed ID: 9353091
[TBL] [Abstract][Full Text] [Related]
34. [Partial re-screening of all negative smears. A method of quality control of pathology department concerning smear screening against cervix cancer].
Jensen ML; Dybdahl H; Svanholm H
Ugeskr Laeger; 2000 May; 162(21):3024-7. PubMed ID: 10850190
[TBL] [Abstract][Full Text] [Related]
35. Screening for cancer of the cervix in elderly women.
Fletcher A
Lancet; 1990 Jan; 335(8681):97-9. PubMed ID: 1967429
[TBL] [Abstract][Full Text] [Related]
36. Pap smears, elderly women, and Medicare.
Power EJ
Cancer Invest; 1993; 11(2):164-8. PubMed ID: 8462016
[No Abstract] [Full Text] [Related]
37. Is proficiency testing in cervical cytology proficient?
Herbert A
J Clin Pathol; 1997 Jul; 50(7):536-7. PubMed ID: 9306928
[No Abstract] [Full Text] [Related]
38. Clinical and cost implications of new technologies for cervical cancer screening: the impact of test sensitivity.
Hutchinson ML; Berger BM; Farber FL
Am J Manag Care; 2000 Jul; 6(7):766-80. PubMed ID: 11067374
[TBL] [Abstract][Full Text] [Related]
39. [Costs of population cervical cancer screening program in Poland between 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Kedzia W; Molińska-Glura M; Seroczyński P; Januszek-Michalecka L; Rokita W; Nowak-Markwitz E
Ginekol Pol; 2010 Oct; 81(10):750-6. PubMed ID: 21117303
[TBL] [Abstract][Full Text] [Related]
40. Cervical-cancer screening: attendance and cost-effectiveness.
Koopmanschap MA; van Oortmarssen GJ; van Agt HM; van Ballegooijen M; Habbema JD; Lubbe KT
Int J Cancer; 1990 Mar; 45(3):410-5. PubMed ID: 2106499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
